Erste Asset Management Gmb H Stoke Therapeutics, Inc. Transaction History
Erste Asset Management Gmb H
- $11.9 Trillion
- Q2 2025
A detailed history of Erste Asset Management Gmb H transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 396,000 shares of STOK stock, worth $12.1 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
396,000
Previous 396,000
-0.0%
Holding current value
$12.1 Million
Previous $2.67 Billion
69.01%
% of portfolio
0.04%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding STOK
# of Institutions
138Shares Held
58MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$165 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$165 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$156 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$141 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$133 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.2B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...